Drug · DIN 02240520
MAXALT
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 15, 2013; first marketed August 31, 1999.
- Drug Identification Number (DIN)
- 02240520
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 9, 2005: NOC 7092New Drug Submission (NDS) · Manufacturer name change
- July 16, 1999: NOC 2030New Drug Submission (NDS)
Other DINs named MAXALT
- DIN 02240521 · Marketed